The Cooper Companies, Inc.
COO
Κατάταξη σε μετοχές
#1886
The Cooper Companies, Inc. (COO) operates as a global medical device firm,... The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
Τιμή μετοχής
$59.03
Κεφαλαιοποίηση
$11.23B
Αλλαγή (1 ημέρα)
1.50%
Αλλαγή (1 έτος)
-21.28%
Χώρα
US
Εμπόριο The Cooper Companies, Inc. (COO)
Κατηγορία
Healthcare
Κέρδη για την The Cooper Companies, Inc. (COO)
Κέρδη τον Jul 2026 TTM: $462.40M
Σύμφωνα με τις τελευταίες οικονομικές αναφορές της The Cooper Companies, Inc., τα τρέχοντα κέρδη της εταιρείας είναι $462.40M. Το 2024, η εταιρεία παρουσίασε κέρδη $582.30M, αύξηση σε σχέση με των κερδών του 2023 που ήταν $412.90M. Τα κέρδη που εμφανίζονται σε αυτή τη σελίδα είναι πριν από τόκους και φόρους, γνωστά και ως EBIT.
Ιστορικό κερδών για την The Cooper Companies, Inc. από 2000 έως 2026
Κέρδη στο τέλος κάθε έτους
| Έτος | Κέρδη | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $462.40M | -18.38% |
| 2025 | $566.50M | -2.71% |
| 2024 | $582.30M | 41.03% |
| 2023 | $412.90M | -13.13% |
| 2022 | $475.30M | -3.30% |
| 2021 | $491.50M | 84.43% |
| 2020 | $266.50M | -44.18% |
| 2019 | $477.40M | 43.84% |
| 2018 | $331.90M | -15.76% |
| 2017 | $394.00M | 33.27% |
| 2016 | $295.63M | 37.19% |
| 2015 | $215.49M | -27.33% |
| 2014 | $296.53M | -5.04% |
| 2013 | $312.27M | 13.37% |
| 2012 | $275.45M | 42.90% |
| 2011 | $192.76M | 54.92% |
| 2010 | $124.43M | 8.36% |
| 2009 | $114.83M | 50.68% |
| 2008 | $76.21M | 11,240.33% |
| 2007 | $672.00K | -99.08% |
| 2006 | $73.34M | -32.38% |
| 2005 | $108.46M | -3.58% |
| 2004 | $112.49M | 24.32% |
| 2003 | $90.49M | 38.85% |
| 2002 | $65.17M | 25.02% |
| 2001 | $52.13M | 23.74% |
| 2000 | $42.13M | 0.00% |
Κέρδη παρόμοιων εταιρειών ή ανταγωνιστών
| Εταιρεία | Κέρδη | Διαφορά Κερδών | Χώρα |
|---|---|---|---|
| $3.81B | 723.05% |
US
|
|
| $4.11B | 788.59% |
FR
|
|
| - | - |
JP
|
|
| $1.59B | 243.86% |
US
|
|
| - | - |
CH
|
